Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Xếp hạng trong cổ phiếu
#2008
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Giá cổ phiếu
$6.40
Vốn hóa thị trường
$10.19B
Thay đổi (1 ngày)
-0.77%
Thay đổi (1 năm)
27.14%
Quốc gia
CN
Giao dịch Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Danh mục
Healthcare
Lịch sử cổ tức của Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Sichuan Kelun Pharmaceutical Co., Ltd. Class A (mã cổ phiếu: 002422) đã thực hiện tổng cộng 19 lần chi trả cổ tức.
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $5.22
Tỷ suất cổ tức (TTM): 0.0139
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $5.22
Tỷ suất cổ tức (TTM): 0.0139
Các khoản chi trả cổ tức của Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422) từ 2011 đến 2026
Các khoản chi trả cổ tức hàng năm
| Năm | Cổ tức (đã điều chỉnh chia tách cổ phiếu) | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.126 | -79.97% |
| 2025 | $0.629 | -40.66% |
| 2024 | $1.06 | 72.08% |
| 2023 | $0.616 | 44.60% |
| 2022 | $0.426 | 33.63% |
| 2021 | $0.3188 | -24.99% |
| 2020 | $0.425 | 102.77% |
| 2019 | $0.2096 | 0.29% |
| 2018 | $0.209 | 50.14% |
| 2017 | $0.1392 | 0.14% |
| 2016 | $0.139 | 11.20% |
| 2015 | $0.125 | 50.06% |
| 2014 | $0.0833 | 0.00% |
| 2013 | $0.0833 | 0.00% |
| 2012 | $0.0833 | 0.00% |
| 2011 | $0.0833 | 0.00% |
Danh sách tất cả các khoản chi trả cổ tức
| Năm | Cổ tức | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.126 | -79.97% |
| 2025 | $0.629 | -40.66% |
| 2024 | $1.06 | 72.08% |
| 2023 | $0.616 | 44.60% |
| 2022 | $0.426 | 33.63% |
| 2021 | $0.3188 | -24.99% |
| 2020 | $0.425 | 102.77% |
| 2019 | $0.2096 | 0.29% |
| 2018 | $0.209 | 50.14% |
| 2017 | $0.1392 | 0.14% |
| 2016 | $0.139 | -44.40% |
| 2015 | $0.25 | 0.00% |
| 2014 | $0.25 | 0.00% |
| 2013 | $0.25 | 0.00% |
| 2012 | $0.25 | -50.00% |
| 2011 | $0.5 | 0.00% |
Cổ tức của các công ty tương tự hoặc đối thủ
| Công ty | Số lần chi trả cổ tức | Quốc gia |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
